Disease management

Radiologist examining a mammogram scan on a monitor
By  Mallory Hackett 01:10 pm May 11, 2021
A new startup called Whiterabbit has emerged from stealth to announce its new CEO and the FDA clearance of its artificial intelligence-enabled breast cancer screening product. The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection, with the goal of eradicating late-stage breast cancers in the U.S. by 2025. The WRDensity...
Hand holding Bigfoot rapid-acting smart insulin pen
By  Mallory Hackett 11:58 am May 10, 2021
This morning, Bigfoot Biomedical announced it has received FDA 510(k) clearance for its Bigfoot Unity Diabetes Management System. The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes who use multiple-dose injection therapy. Included in the Bigfoot Unity System are two smartpen caps for both rapid- and long-acting insulin, a connected mobile app, an...
Viome's Health Intelligence kit
By  Mallory Hackett 11:24 am May 7, 2021
Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that detect early signs of oral cancer and throat cancer. The FDA designation validates the technology used in Viome’s at-home Health Intelligence Test that analyzes users’ microbial, human and mitochondrial...
Shaking Hands
By  Mallory Hackett 11:26 am May 6, 2021
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products. The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche. Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
Piggybank with a stethoscope and money
By  Mallory Hackett 10:41 am May 5, 2021
Vida Health, a virtual chronic condition care platform, announced today it has raised $110 million in its Series D funding round led by General Atlantic, Centene and AXA Venture Partners. Additional support was provided by Ardea Partners, Ally Bridge Group, AME Cloud Ventures, Aspect Ventures, Canvas Ventures, Guidewell, NGP Capital and Workday Ventures. WHAT IT DOES Vida Health’s digital...
Business people shaking hands
By  Mallory Hackett 11:48 am May 3, 2021
MindMaze Healthcare, a digital neurotherapeutics company, is expanding its geographical footprint to patients in Latin America, the Middle East, Spain and Switzerland through a series of new partnerships. The company has inked deals with Peruvian medical biotech company Surgicorp, Saudi Arabian medical company Alkholi, Spanish neurorehabilitation clinic Guttmann Barcelona and Swedish...
Eden Health Employer Dashboard
By  Mallory Hackett 04:06 pm April 28, 2021
Eden Health, a direct-to-employer health provider that offers virtual and in-person care and insurance navigation, has expanded its COVID-19 workplace offerings to include opt-in vaccine record-sharing. With this consent-driven initiative, Eden Health aims to give both employers and their workforce assurance that jobsites can safely reopen and remain open. “I think that there’s a lot of companies...
Piggybank with a stethoscope and money
By  Mallory Hackett 01:12 pm April 27, 2021
Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors. The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement. WHAT IT DOES Glytec’s eGlycemic Management System is centered on its FDA-cleared...
Woman unboxing Virta Health kit
By  Mallory Hackett 10:27 am April 20, 2021
Digital diabetes management company Virta Health scored $133 million in a Series E funding round led by Tiger Global. This financing comes on the heels of Virta’s $65 million Series D in December, which propelled it into becoming a unicorn company. With the latest cash infusion, Virta says it has doubled its valuation to $2 billion. WHAT IT DOES Virta claims it can reverse Type 2 diabetes with...
x-ray view of kidneys
By  Mallory Hackett 02:27 pm April 15, 2021
Clinical diagnostic company Renalytix AI has expanded its partnership with the Joslin Diabetes Center to integrate new biomarkers for kidney disease discovered by the center's researchers into the company’s KidneyIntelX platform. KidneyIntelX is an in vitro diagnostic platform that assesses the risk of adverse kidney outcomes in patients with Type 2 diabetes and early-stage kidney disease. By...